Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
PROCAINE HYDROCHLORIDE, EPINEPHRINE
Norbrook Laboratories Limited
QN01BA52
PROCAINE HYDROCHLORIDE, EPINEPHRINE
Unknown
Solution for Injection
POM
Bovine
Procaine, combinations
Neurological Preparations
Authorised
2009-07-17
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Adrenacaine Solution for Injection for Cattle. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for injection. A clear colourless solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The product is indicated for use in minor surgical procedures particularly dehorning and disbudding in cattle. 4.3 CONTRAINDICATIONS Do not administer by intravenous, intra-articular or epidural injection. Do not use in cases of hypersensitivity to the active substances or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known. ACTIVE SUBSTANCE: Procaine Hydrochloride 50 mg/ml Adrenaline (Epinephrine) (as Adrenaline Tartrate) 0.02 mg/ml EXCIPIENTS: Chlorocresol (as preservative) 1.0 mg/ml Sodium Metabisulphite E223 (as antioxidant) 1.0 mg/ml For the full list of excipients, see section 6.1. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 10/03/2015_ _CRN 7020142_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE I SPECIAL PRECAUTIONS FOR USE IN ANIMALS Care should be taken not to inject the product intravascularly. II SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Care should be taken to avoid accidental self-injection. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or label to the physician. Immediately wash off any splashes to the eyes or skin with copious amounts of water. Seek medical attention if irritation occurs. Wash hands after use. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) None known. 4.7 USE DURING PREGNA Preberite celoten dokument